Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
New attack waves from the 'PhantomRaven' supply-chain campaign are hitting the npm registry, with dozens of malicious packages that exfiltrate sensitive data from JavaScript developers.
4d
ThreatDown Uncovers First Cyber Attack Abusing Deno JavaScript Runtime for Fileless Malware Delivery
ThreatDown, the corporate business unit of Malwarebytes, today published research documenting what researchers believe to be the first documented case of attackers abusing the Deno JavaScript runtime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results